Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Prospective, Observational, Multicentre Study to Confirm the Performance of Molecular Screening for Early Detection of Preeclampsia

NCT06716242 is registered in ClinicalTrials.gov with iPremom as lead sponsor.

NCT NCT06716242
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06716242 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Prospective, Observational, Multicentre Study to Confirm the Performance of Molecular Screening for Early Detection of Preeclampsia
Lead sponsor
iPremom
Phase
Observational
Overall status
Recruiting
Start date
December 2, 2024
Completion date
February 28, 2027
Enrollment
7,473 (estimated)
Sites
11

Conditions

As the registry lists them; a condition with its own page is linked.

preeclampsia (pe)